{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:23:23Z","timestamp":1792589003106,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["2022xxxx0005"],"award-info":[{"award-number":["2022xxxx0005"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["2019xxxx0054"],"award-info":[{"award-number":["2019xxxx0054"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejphar.2024.177147","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T23:20:55Z","timestamp":1732058455000},"page":"177147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Empagliflozin prevents TNF-\u03b1 induced endothelial dysfunction under flow -the potential involvement of calcium and sodium-hydrogen exchanger"],"prefix":"10.1016","volume":"986","author":[{"given":"Xiaoling","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0081-6264","authenticated-orcid":false,"given":"Mengnan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Wolfsgruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3771-6893","authenticated-orcid":false,"given":"Olivia C.","family":"Klatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8248-0244","authenticated-orcid":false,"given":"Markus W.","family":"Hollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4412-9183","authenticated-orcid":false,"given":"Benedikt","family":"Preckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8361-2448","authenticated-orcid":false,"given":"Coert J.","family":"Zuurbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-9042","authenticated-orcid":false,"given":"Nina C.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejphar.2024.177147_bib1","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1084\/jem.20180483","article-title":"Piezo1 and G(q)\/G(11) promote endothelial inflammation depending on flow pattern and integrin activation","volume":"215","author":"Albarran-Juarez","year":"2018","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177147_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)\/H(+) exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2024.177147_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103010","article-title":"EmpaglifloUthman et al. 2018, 2022zin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress","volume":"69","author":"Cai","year":"2024","journal-title":"Redox Biol."},{"issue":"8","key":"10.1016\/j.ejphar.2024.177147_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10081228","article-title":"Does empagliflozin modulate leukocyte-endothelium interactions, oxidative stress, and inflammation in type 2 diabetes?","volume":"10","author":"Canet","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2024.177147_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fcell.2019.00280","article-title":"Differential regulation of LPS-mediated VE-cadherin disruption in human endothelial cells and the underlying signaling pathways: a mini review","volume":"7","author":"Chan","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177147_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12933-022-01480-1","article-title":"Direct cardiac effects of SGLT2 inhibitors","volume":"21","author":"Chen","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2024.177147_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1179131","article-title":"Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177147_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/CIRCULATIONAHA.122.061688","article-title":"Sodium glucose cotransporter-2 inhibitor empagliflozin reduces infarct size independently of sodium glucose cotransporter-2","volume":"147","author":"Chen","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.177147_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2017.04.003","article-title":"Serum TNF-alpha concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: a systematic review and meta-analysis","volume":"186","author":"Chen","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ejphar.2024.177147_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114198","article-title":"Effects of shear stress on vascular endothelial functions in atherosclerosis and potential therapeutic approaches","volume":"158","author":"Cheng","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177147_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12933-023-01756-0","article-title":"Empagliflozin suppressed cardiac fibrogenesis through sodium-hydrogen exchanger inhibition and modulation of the calcium homeostasis","volume":"22","author":"Chung","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"issue":"14","key":"10.1016\/j.ejphar.2024.177147_bib12","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1093\/cvr\/cvaa323","article-title":"Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+\/H+ exchanger-1 or lower [Na+]i in the heart","volume":"117","author":"Chung","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"1\u20132","key":"10.1016\/j.ejphar.2024.177147_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11010-019-03555-2","article-title":"Empagliflozin restores the integrity of the endothelial glycocalyx in vitro","volume":"459","author":"Cooper","year":"2019","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177147_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCRESAHA.123.322798","article-title":"PIEZO ion channels in cardiovascular functions and diseases","volume":"134","author":"Coste","year":"2024","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177147_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00018-016-2325-8","article-title":"Cell-cell junctional mechanotransduction in endothelial remodeling","volume":"74","author":"Dorland","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177147_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119481","article-title":"Empagliflozin ameliorates bleomycin-induced pulmonary fibrosis in rats by modulating Sesn2\/AMPK\/Nrf2 signaling and targeting ferroptosis and autophagy","volume":"24","author":"El-Horany","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177147_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.redox.2015.08.010","article-title":"Calcium and ROS: a mutual interplay","volume":"6","author":"Gorlach","year":"2015","journal-title":"Redox Biol."},{"issue":"680","key":"10.1016\/j.ejphar.2024.177147_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abp9952","article-title":"SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant","volume":"15","author":"Guo","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177147_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2019.04.003","article-title":"Cardiac microvascular endothelial enhancement of cardiomyocyte function is impaired by inflammation and restored by empagliflozin","volume":"4","author":"Juni","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177147_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/01.RES.0000156652.99586.9f","article-title":"Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues","volume":"96","author":"Lambeng","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.177147_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114228","article-title":"Canagliflozin inhibits inflammasome activation in diabetic endothelial cells - revealing a novel calcium-dependent anti-inflammatory effect of canagliflozin on human diabetic endothelial cells","volume":"159","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177147_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116044","article-title":"Sodium glucose Co-transporter 2 inhibitors ameliorate endothelium barrier dysfunction induced by cyclic stretch through inhibition of reactive oxygen species","volume":"22","author":"Li","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177147_bib23","article-title":"Empagliflozin prevents oxidative stress in human coronary artery endothelial cells via the NHE\/PKC\/NOX axis","author":"Li","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2024.177147_bib24","article-title":"Piezo1 channels as force sensors in mechanical force-related chronic inflammation","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177147_bib25","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.7150\/thno.75121","article-title":"SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia\/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways","volume":"12","author":"Ma","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177147_bib26","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1038\/s41598-018-23420-4","article-title":"Canagliflozin inhibits interleukin-1beta-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms","volume":"8","author":"Mancini","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177147_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/17425255.2015.986457","article-title":"Pharmacokinetics, pharmacodynamics and clinical efficacy of dapagliflozin for the treatment of type 2 diabetes","volume":"11","author":"Maranghi","year":"2015","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177147_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023236118","article-title":"Longitudinal shear stress response in human endothelial cells to atheroprone and atheroprotective conditions","volume":"118","author":"Maurya","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2024.177147_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1196033","article-title":"Monocyte-endothelial cell interactions in vascular and tissue remodeling","volume":"14","author":"Medrano-Bosch","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177147_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.biocel.2008.07.018","article-title":"Monocyte chemoattractant protein-1: a key mediator in inflammatory processes","volume":"41","author":"Melgarejo","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177147_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12195-019-00585-0","article-title":"Endothelial cell biomechanical responses are dependent on both fluid shear stress and tensile strain","volume":"12","author":"Meza","year":"2019","journal-title":"Cell. Mol. Bioeng."},{"issue":"16","key":"10.1016\/j.ejphar.2024.177147_bib33","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/CIRCULATIONAHA.122.057364","article-title":"Empagliflozin inhibits cardiac late sodium current by Ca\/Calmodulin-Dependent kinase II","volume":"146","author":"Mustroph","year":"2022","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ejphar.2024.177147_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189821","article-title":"Reactive oxygen species and endothelial Ca(2+) signaling: brothers in arms or partners in crime?","volume":"22","author":"Negri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177147_bib35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/msy.2002.125305","article-title":"Tyrosine phosphorylation of vascular endothelial cadherin and the regulation of microvascular permeability","volume":"132","author":"Nwariaku","year":"2002","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.ejphar.2024.177147_bib36","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1089\/ars.2009.2487","article-title":"Molecular mechanisms responsible for the atheroprotective effects of laminar shear stress","volume":"11","author":"Pan","year":"2009","journal-title":"Antioxidants Redox Signal."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177147_bib37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12933-021-01252-3","article-title":"Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle-stimulated endothelial senescence and dysfunction: protective effect of gliflozins","volume":"20","author":"Park","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177147_bib38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10557-021-07311-x","article-title":"Empagliflozin ameliorates ouabain-induced Na+ and Ca2+ dysregulations in ventricular myocytes in an Na+-Dependent manner","volume":"37","author":"Peng","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"22","key":"10.1016\/j.ejphar.2024.177147_bib39","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.121.053350","article-title":"Cardiac late sodium channel current is a molecular target for the sodium\/glucose cotransporter 2 inhibitor empagliflozin","volume":"143","author":"Philippaert","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.177147_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yjmcc.2013.09.013","article-title":"Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress","volume":"65","author":"Prasad","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177147_bib41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40262-013-0126-x","article-title":"Pharmacokinetic and pharmacodynamic profile of empagliflozin, a sodium glucose co-transporter 2 inhibitor","volume":"53","author":"Scheen","year":"2014","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177147_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/17425255.2017.1258401","article-title":"Evaluation of the pharmacokinetics, pharmacodynamics and clinical efficacy of empagliflozin for the treatment of type 2 diabetes","volume":"13","author":"Tomlinson","year":"2017","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2024.177147_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3233\/CH-2010-1346","article-title":"Role of shear stress patterns in the TNF-alpha-induced atherogenic protein expression and monocytic cell adhesion to endothelium","volume":"46","author":"Urschel","year":"2010","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177147_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","article-title":"Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)\/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation","volume":"61","author":"Uthman","year":"2018","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177147_bib45","doi-asserted-by":"crossref","first-page":"865","DOI":"10.33594\/000000178","article-title":"Empagliflozin and dapagliflozin reduce ROS generation and restore NO bioavailability in tumor necrosis factor alpha-stimulated human coronary arterial endothelial cells","volume":"53","author":"Uthman","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.ejphar.2024.177147_bib46","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10557-020-07083-w","article-title":"Novel anti-inflammatory effects of canagliflozin involving hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cells","volume":"35","author":"Uthman","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2024.177147_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112515","article-title":"Empagliflozin reduces oxidative stress through inhibition of the novel inflammation\/NHE\/[Na(+)](c)\/ROS-pathway in human endothelial cells","volume":"146","author":"Uthman","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.177147_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yjmcc.2022.04.011","article-title":"Targeting endothelial dysfunction and inflammation","volume":"168","author":"Wang","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177147_bib49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood.2021014614","article-title":"Mechanosensation by endothelial PIEZO1 is required for leukocyte diapedesis","volume":"140","author":"Wang","year":"2022","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177147_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12358","article-title":"Role of moesin, Src, and ROS in advanced glycation end product-induced vascular endothelial dysfunction","volume":"24","author":"Zhang","year":"2017","journal-title":"Microcirculation"},{"issue":"21","key":"10.1016\/j.ejphar.2024.177147_bib51","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.21037\/atm-20-3426","article-title":"Adaptation of endothelial cells to shear stress under atheroprone conditions by modulating internalization of vascular endothelial cadherin and vinculin","volume":"8","author":"Zhong","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"14","key":"10.1016\/j.ejphar.2024.177147_bib52","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/cvr\/cvab129","article-title":"Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na+\/H+ exchanger 1: persistent inhibition under various experimental conditions","volume":"117","author":"Zuurbier","year":"2021","journal-title":"Cardiovasc. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924008379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924008379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:42:44Z","timestamp":1777387364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924008379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S0014299924008379"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177147","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin prevents TNF-\u03b1 induced endothelial dysfunction under flow -the potential involvement of calcium and sodium-hydrogen exchanger","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177147"}}